AbbVie (ABBV) Minority Interest (2020 - 2026)

AbbVie (ABBV) has reported Minority Interest for 7 consecutive years, with $47.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Minority Interest rose 4.44% year-over-year to $47.0 million in Q2 2026; TTM through Jun 2026 was $47.0 million, a 4.44% increase from a year earlier, with the FY2025 full-year figure at $42.0 million, up 7.69% from the prior year.
• Minority Interest was $47.0 million for Q2 2026 at AbbVie, up from $44.0 million in the prior quarter.
• Over five years, Minority Interest peaked at $47.0 million in Q2 2026 and troughed at $29.0 million in Q1 2023.
• A 5-year average of $38.3 million and a median of $39.0 million in 2024 frame the typical range for Minority Interest.
• Across the five-year window, Minority Interest surged 40.0% in 2022 and decreased 8.57% in 2023, its largest moves.
• Over 5 years, Minority Interest stood at $33.0 million in 2022, then advanced by 12.12% to $37.0 million in 2023, then grew by 5.41% to $39.0 million in 2024, then grew by 7.69% to $42.0 million in 2025, then gained by 11.9% to $47.0 million in 2026.
• The last three Minority Interest figures came in at $47.0 million (Q2 2026), $44.0 million (Q1 2026), and $42.0 million (Q4 2025), per Business Quant data.